FDA Adverse Event Injury Summary report: N

CYPHER SIROLIMUS-ELUTING CORONARY STENT

MDR report key: 1153061 · Received September 8, 2008

Report

Report Number
9616099-2008-02176
Event Type
Injury
Date Received
September 8, 2008
Date of Event
February 14, 2007
Report Date
August 13, 2008
Manufacturer
CORDIS DE MEXICO
Product Code
NIQ
PMA / PMN Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

THE REPORT IS FROM THE STUDY. THE PATIENT WAS A MALE WITH A HISTORY OF HYPERTENSION, HYPERLIPIDEMIA, SMOKING, DIABETES, MYOCARDIAL INFARCTION, CONGESTIVE HEART FAILURE, AND CEREBROVASCULAR DISEASE. THE INDICATION FOR THE INDEX PROCEDURE WAS AN ACUTE MYOCARDIAL INFARCTION GREATER THAN 72 HOURS PRIOR TO THE PROCEDURE. THE FIRST TARGET LESION WAS THE MID LAD. VESSEL DIAMETER WAS 2.25MM AND THE LESION LENGTH WAS 15MM. PRE-PROCEDURE STENOSIS WAS 95%. POST-PROCEDURE STENOSIS WAS 0%. THE LESION WAS DE NOVO, IRREGULAR CONTOUR, AND A TYPE C CLASSIFICATION. THE LESION WAS PRE-DILATED WITH A 2 X 20MM BALLOON AT 14ATM. A CYPHER WAS DEPLOYED AT 18ATM. THE 2ND TARGET LESION WAS THE PROXIMAL LAD. VESSEL DIAMETER WAS 2.75MM AND THE LESION LENGTH WAS 15MM. PRE-PROCEDURE STENOSIS WAS 90%, POST-PROCEDURE STENOSIS WAS 0%. THE LESION WAS DE NOVO, IRREGULAR CONTOUR AND A TYPE C CLASSIFICATION. THE LESION WAS NOT PRE-DILATED. A CYPHER WAS DEPLOYED AT 20ATM AND POST-DILATED BECAUSE THE STENT WAS NOT FULLY EXPANDED. A CYPHER WAS DEPLOYED AT 18ATM TO TREAT A TYPE A DISSECTION WHICH WAS NOTICED AFTER THE FIRST STENT WAS IMPLANTED. THE CYPHER WAS POST-DILATED BECAUSE IT WAS NOT FULLY EXPANDED. THE 3RD TARGET LESION WAS THE FIRST OBTUSE MARGINAL. VESSEL DIAMETER WAS 2.5MM AND THE LESION LENGTH WAS 19MM. PRE-PROCEDURE STENOSIS WAS 90%, POST-PROCEDURE STENOSIS WAS 0%. THE LESION WAS DE NOVO, IRREGULAR CONTOUR AND TYPE B2 CLASSIFICATION. THE LESION WAS NOT PRE-DILATED. A CYPHER WAS DEPLOYED IN THE LESION AT 18ATM. THE PATIENT WAS DISCHARGED 3 WEEKS POST-PROCEDURE. THIS PRODUCT, NOTED IN D4, IS DISTRIBUTED OUTSIDE THE UNITED STATES. HOWEVER IT IS SIMILAR TO THE US DISTRIBUTED DRUG-ELUTING STENTS. THE STERILE LOT NUMBER FOR THE PRODUCT IS UNKNOWN THEREFORE A DEVICE HISTORY REPORT REVIEW COULD NOT BE CONDUCTED. DISSECTIONS ARE A KNOWN POTENTIAL ADVERSE EVENT ASSOCIATED WITH IMPLANTING CORONARY STENTS. THE IFU CAUTIONS NOT TO INFLATE THE STENT DELIVERY BALLOON ABOVE RATE BURST PRESSURE OF 16ATMS AS THIS MAY LEAD TO BALLOON RUPTURE OR POSSIBLE DISSECTION. REVIEW OF THE AVAILABLE INFORMATION SUGGESTS THAT THE PATIENT'S EXTENSIVE MEDICAL HISTORY AND/OR PROCEDURAL FACTORS MAY HAVE CONTRIBUTED TO THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CYPHER SIROLIMUS-ELUTING CORONARY STENT DRUG-ELUTING STENT (NIQ) NIQ CORDIS DE MEXICO NA UNK

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention DEVICES: 7FR GUIDING CATHETER| ACE INHIBITORS| 3 X 10MM BALLOON| AND 2 X 20MM BALLOON| CLOPIDOGREL| HEPARIN| BETA BLOCKERS| AND INSULIN| STATINS| MEDICATIONS: ASPIRIN